- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 17 Jun 2023 - 23 Jun 2023
RESEARCH TYPE:
Basic Science
Pharmacology/Drug Development
PAIN TYPE:
Arthritis, Inflammation/Inflammatory
2023 Jun 10
Colloids Surf B Biointerfaces
228
Meloxicam (MLX) is prescribed for the management of pain and inflammation allied with osteoarthritis (OA). However, MLX causes intestinal damage in long term administration. Hence, meloxicam loaded emulgel (MLX-emulgel) was optimized, formulated and examined under stringent parameters in monosodium-iodoacetate (MIA) induced knee OA in Wistar rats.